Con: Higher serum bicarbonate in dialysis patients is protective

Nephrol Dial Transplant. 2016 Aug;31(8):1226-9. doi: 10.1093/ndt/gfw255. Epub 2016 Jul 13.


Metabolic acidosis is often observed in advanced chronic kidney disease, with deleterious consequences on the nutritional status, bone and mineral status, inflammation and mortality. Through clearance of the daily acid load and a net gain in alkaline buffers, dialysis therapy is aimed at correcting metabolic acidosis. A normal bicarbonate serum concentration is the recommended target in dialysis patients. However, several studies have shown that a mild degree of metabolic acidosis in patients treated with dialysis is associated with better nutritional status, higher protein intake and improved survival. Conversely, a high bicarbonate serum concentration is associated with poor nutritional status and lower survival. It is likely that mild acidosis results from a dietary acid load linked to animal protein intake. In contrast, a high bicarbonate concentration in patients treated with dialysis could result mainly from an insufficient dietary acid load, i.e. low protein intake. Therefore, a high pre-dialysis serum bicarbonate concentration should prompt nephrologists to carry out nutritional investigations to detect insufficient dietary protein intake. In any case, a high bicarbonate concentration should be neither a goal of dialysis therapy nor an index of adequate dialysis, whereas mild acidosis could be considered as an indicator of appropriate protein intake.

Keywords: chronic kidney disease; dialysis; haemodialysis; metabolic acidosis; peritoneal dialysis.

MeSH terms

  • Acidosis / blood
  • Acidosis / chemically induced
  • Acidosis / prevention & control
  • Bicarbonates / blood*
  • Dialysis Solutions
  • Fluid Therapy
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / prevention & control*
  • Renal Dialysis*


  • Bicarbonates
  • Dialysis Solutions